行情

RGEN

RGEN

Repligen Corp
NASDAQ

实时行情|Nasdaq Last Sale

94.33
-2.21
-2.29%
盘后: 94.36 +0.03 +0.03% 16:11 04/01 EDT
开盘
94.08
昨收
96.54
最高
96.01
最低
92.00
成交量
55.14万
成交额
--
52周最高
109.94
52周最低
52.87
市值
49.13亿
市盈率(TTM)
214.87
分时
5日
1月
3月
1年
5年

分析师评级

10位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测RGEN价格均价为112.50,最高价位120.00,最低价为98.00。

EPS

RGEN 新闻

更多
  • Novavax and Regeneron- Speculating on Vaccines
  • MoneyShow · 17小时前
  • Trading Plan: Analyze Stocks In 3 Categories - 'Pro Virus,' 'Pro+Post' And 'Post-Only'
  • Seeking Alpha - Article · 2天前
  • Last Week Was Challenging, Friday Had Positives, There's Hope For This Week
  • Seeking Alpha - Article · 03/23 01:25
  • Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report?
  • Zacks · 03/21 16:30

所属板块

医疗设备、用品及经销
-4.79%
医疗设备和用品
-4.98%

热门股票

代码
价格
涨跌幅

RGEN 简况

Repligen Corporation is a bioprocessing company. The Company is focused on the development, manufacture and commercialization of products used to improve the interconnected phases of the biological drug manufacturing process. The Company's portfolio includes protein products, chromatography products, and filtration products. It provides Protein A ligands, a component of Protein A chromatography resins (media) used in the purification of virtually all monoclonal antibody (mAb)-based drugs on the market or in development. Its chromatography portfolio includes various products used in the downstream purification and quality control of biological drugs. Its OPUS pre-packed chromatography columns (PPCs) are used in the purification of clinical-stage biologics. Its filtration products include XCell Alternating Tangential Flow (ATF) Systems and Sius tangential flow filtration (TFF) cassettes. Sius TFF cassettes are used to concentrate clinical and commercial-stage biologic drugs.
展开

微牛提供Repligen Corporation(NASDAQ-RGEN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的RGEN股票新闻,以帮助您做出投资决策。